MCTANasdaqServices-Misc Health & Allied Services, NEC

Charming Medical Ltd

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 30, 2026

$29.36+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

Debt

Borrowings on the balance sheet, Mar 31, 2026

Charming Medical reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Bond issues

Individual notes and bonds outstanding

Bond-level data is not connected yet

Coupon, maturity and amount of each note will come from the debt footnote in Charming Medical's annual report. Trading prices and yields need FINRA TRACE data.

Where these numbers come from

Parsed from the XBRL in Charming Medical's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is MCTA.

Revenue growth-22.7% · median -29.7%

Gross margin99.3% · median 40.1%

Operating margin-0.6% · median -81.8%

Net margin-0.5% · median -101.5%

Company	Revenue	Growth
MRAI	$16.64M	-29.7%
PFHO	$6.44M	-3.4%
MCTA	$4.81M	-22.7%
MGRX	$315.23K	-38.9%
NIVF	–	–
EUDA	–	–

Company

Exchange: Nasdaq
Industry: Services-Misc Health & Allied Services, NEC
Employees: 29
Auditor: WWC, P.C.
SEC CIK: 2035992

Advertisement
300 × 250